Business

Oppenheimer initiates Ocugen stock rating at Outperform on gene therapy potential

Published

on


Oppenheimer initiates Ocugen stock rating at Outperform on gene therapy potential

Leave a Reply

Your email address will not be published. Required fields are marked *

Trending

Exit mobile version